FIRST CHINA PHARMACEUTICAL GROUP, INC. Net Income
FIRST CHINA PHARMACEUTICAL GROUP, INC. reported Net Income of $990.98 thousand for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-11-19.
Discontinued › Income Statement
us-gaap:NetIncomeLoss · last filed 2012-11-19
- FIRST CHINA PHARMACEUTICAL GROUP, INC. net income (loss) attributable to parent for the quarter ending 2012-09-30 was $990.98K, a 18.51% increase year-over-year.
- FIRST CHINA PHARMACEUTICAL GROUP, INC. net income (loss) attributable to parent for the quarter ending 2012-06-30 was $2.30M, a 33.20% increase year-over-year.
- FIRST CHINA PHARMACEUTICAL GROUP, INC. net income (loss) attributable to parent for the quarter ending 2012-03-31 was -$1.17M.
- FIRST CHINA PHARMACEUTICAL GROUP, INC. net income (loss) attributable to parent for the quarter ending 2011-09-30 was $836.19K, a 14.40% decline year-over-year.
- FIRST CHINA PHARMACEUTICAL GROUP, INC. net income (loss) attributable to parent for fiscal 2011 was $778.92K, a 71.80% decline from fiscal 2010.
- FIRST CHINA PHARMACEUTICAL GROUP, INC. net income (loss) attributable to parent for fiscal 2010 was $2.76M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 3 month as first filed | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 6 month as first filed | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 9 month as first filed | Net Income (Loss) Attributable to Parent 12 month | Net Income (Loss) Attributable to Parent 12 month as first filed | Net Income (Loss) Attributable to Parent 21 month |
|---|---|---|---|---|---|---|---|---|---|
| 2012-09-30 | $990.98K 10-Q · filed 2012-11-19 | $3.29M derived: sum of 2 quarters · filed 2012-11-19 | $1.11M 10-Q · filed 2012-11-19 | ||||||
| 2012-06-30 | $2.30M 10-Q/A · filed 2012-08-21 | $740.23K 10-Q/A · filed 2012-08-21 | |||||||
| 2012-03-31 | -$1.17M 10-Q · filed 2012-05-18 | ||||||||
| 2011-12-31 | $4.64M 10-KT/A · filed 2012-11-19 | $4.92M 10-KT · filed 2012-05-02 | $2.65M 10-KT · filed 2012-05-02 | ||||||
| 2011-09-30 | $836.19K 10-Q · filed 2012-11-19 | $493.16K 10-Q · filed 2011-11-14 | $2.56M derived: sum of 2 quarters · filed 2012-11-19 | $2.17M 10-Q · filed 2012-11-19 | $351.83K 10-Q · filed 2011-11-14 | ||||
| 2011-06-30 | $1.73M 10-Q/A · filed 2012-08-21 | $623.39K 10-Q/A · filed 2011-08-24 | $1.39M 10-Q/A · filed 2012-08-21 | -$131.96K 10-Q/A · filed 2011-08-24 | |||||
| 2011-03-31 | -$314.54K 10-Q · filed 2012-05-18 | $778.92K 10-KT/A · filed 2012-11-19 | $2.65M 10-KT · filed 2012-05-02 | ||||||
| 2010-09-30 | $976.82K 10-Q · filed 2011-11-14 | $1.86M derived: sum of 2 quarters · filed 2011-12-02 | $2.66M 10-Q · filed 2011-11-14 | ||||||
| 2010-06-30 | $882.68K 10-Q/A · filed 2011-12-02 | $1.68M 10-Q/A · filed 2011-12-02 | |||||||
| 2010-03-31 | $2.76M 10-KT/A · filed 2012-11-19 |